Efficient production of nanobodies against urease activity of Helicobacter pylori in Pichia pastoris

Background/aim: Helicobacter pylori is a major health problem. One of the therapeutic approaches is administration of antibody against H. pylori. The methylotrophic Pichia pastoris is a suitable host for expression of recombinant antibody fragments. The aims of this study were the expression and the evaluation of camelid nanobody in the yeast Pichia pastoris. Materials and methods: The camelid-derived heavy-chain antibody (nanobody) against the UreC subunit of urease from H. pylori was subcloned in the pPink-HC shuttle vector and transferred into Escherichia coli TOP10. After digestion and purification, the shuttle vector was transformed in the PichiaPink expression system. The expression was evaluated in an in vitro system. Results: The yield of the nanobody expressed in P. pastoris was estimated to be 5 mg/L as compared to 2 mg/L expressed by E. coli. The nanobody was purified and binding affinity to the UreC antigen was evaluated using ELISA. Neutralization abilities of the two nanobodies expressed in yeast and E. coli were compared. The yeast-expressed nanobody specifically detected recombinant UreC and inhibited urease activity with high efficiency. Conclusion: The results suggest attribution of the enhanced quality and quantity of the nanobody produced in P. pastoris to better posttranslational modification and folding in the yeast cell.

PDF

___

1. Sachs G, Weeks DL, Melchers K, Scott DR. The gastric biology of Helicobacter pylori. Annu Rev Physiol 2003; 65: 349-369.
2. Blaser MJ. Who are we? Indigenous microbes and the ecology of human diseases. EMBO Rep 2006; 7: 956-960.
3. Kusters JG, Van Vliet AHM, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Med Rev 2006; 19: 449-490.
4. Safaee Ardekani L, Mousavi Gargari SL, Rasooli I, Rajabibazl M, Mohammadi M, Ebrahimizadeh W, Bakherad H, Zare H. A novel nanobody against urease activity of Helicobacter pylori. Int J Infect Dis 2013; 17: e723-e728.
5. Atherton JC. H. pylori virulence factors. Br Med Bull 1998; 54: 105-120.
6. Prinz C, Hafsi N, Voland P. Helicobacter pylori virulence factors and the host immune response: implications for therapeutic vaccination. Trends Microbiol 2003; 11: 134-138.
7. Veis Malekshahi Z, Mousavi Gargari SL, Rasooli I, Ebrahimizadeh W. Treatment of Helicobacter pylori infection in mice with oral administration of egg yolk-driven anti-UreC immunoglobulin. Microb Pathog 2011; 51: 366-372.
8. Kolkman JA, Law DA. Nanobodies from llamas to therapeutic proteins. Drug Discov Today Technol 2010; 7: 139-146.
9. Ebrahimizadeh W, Mousavi Gargari SL, Rajabibazl M, Safaee Ardekani L, Zare H, Bakherad H. Isolation and characterization of protective anti-LPS nanobody against V. cholerae O1 recognizing Inaba and Ogawa serotypes. Appl Microbiol Biotechnol 2012; 97: 4457-4466.
10. Rajabibazl M, Rasaee MJ, Foruzandeh M, Rahimpour A, Kiani J, Rahbarizadeh F, Alirezapour B, Mohammadi M. Production of chimeric recombinant single domain antibody-green fluorescent fusion protein in Chinese hamster ovary cells. Hybridoma 2007; 26: 1-9.
11. Eyer L, Hruska K. Single-domain antibody fragments derived from heavy-chain antibodies: a review. Vet Med 2012; 57: 439- 513.
12. Deffar K, Shi H, Li L, Wang X, Zhu X. Nanobodies - the new concept in antibody engineering. Afr J Biotechnol 2009; 8: 2645-2652.
13. Van der Vaart J, Pant N, Wolvers D, Bezemer S, Hermans P, Bellamy K. Reduction in morbidity of rotavirus induced diarrhoea in mice by yeast produced monovalent llamaderived antibody fragments. Vaccine 2006; 24: 4130-4137.
14. Cereghino GPL, Cregg JM. Applications of yeast in biotechnology: protein production and genetic analysis. Curr Opin Biotechnol 1999; 10: 422-427.
15. Daly R, Hearn MTW. Expression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production. J Mol Recognit 2004; 18: 119-138.
16. Cregg JM, Cereghino JL, Shi J, Higgins DR. Recombinant protein expression in Pichia pastoris. Mol Biotechnol 2000; 16: 23-52.
17. Balamurugan V, Reddy GR, Suryanaryana VVS. Pichia pastoris: a notable heterologous expression system for the production of foreign proteinsvaccines. Indian J Microbiol 2007; 6: 175- 186.
18. Cereghino GPL, Cereghino JL, Ilgen C, Cregg JM. Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris. Curr Opin Biotechnol 2002; 13: 329-332.
19. Beatty JD, Beatty BG, Vlahos WG. Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay. J Immunol Methods 1987; 100: 173-179.
20. Malfertheiner P, Megraud F, OMorain C, Bazzoli F, ElOmar E, Graham D. Current concepts in the management of Helicobacter pylori infection: the Maastricht III consensus report. Gut 2007; 56: 772-781.
21. Houimel M, Mach JP, Corthesy-Theulaz I, Corthesy B, Fisch I. New inhibitors of Helicobacter pylori urease holoenzyme selected from phage-displayed peptide libraries. Eur J Biochem 1999; 262: 774-780.
22. Ikeda Y, Fujii R, Ogino K, Fukushima K, Hifumi E, Uda T. Immunological features and inhibitory effects on enzymatic activity of monoclonal antibodies against Helicobacter pylori urease. J Ferment Bioeng 1998; 86: 271-276.
23. Nagata K, Mizuta T, Tonokatu Y, Fukuda Y, Okamura H, Hayashi T, Shimoyama T, TamuraT. Monoclonal antibodies against the native urease of Helicobacter pylori: synergistic inhibition of urease activity by monoclonal antibody combinations. Infect Immun 1992; 60: 4826-4831.
24. Yanan W, Quanming Z, Ping L, Gang G, Xiaoqin W. Preparation of anti-Helicobacter pylori UreB monoclonal antibody and the detection of the ability of inhibition the urease activity. J Immunol 2005; 21: 393-396.
25. Rahbarizadeh F, Rasaee MJ, Forouzandeh M, Allameh AA. Over expression of anti-MUC1 single-domain antibody fragments in the yeast Pichia pastoris. Mol Immunol 2006; 43: 426-435.
26. Emberson LM, Trivett AJ, Blower PJ, Nicholls PJ. Expression of an anti-CD33 single-chain antibody by Pichia pastoris. J Immunol Methods 2005; 305: 135-151.
27. Eldin P, Pauza ME, Hieda Y, Lin G, Murtaugh MP, Pentel PR, Pennell AC. High-level secretion of two antibody single chain Fv fragments by Pichia pastoris. J Immunol Methods 1997; 201: 67-75.
28. Verma R, Boleti E, George AJT. Antibody engineering: comparison of bacterial, yeast, insect and mammalian expression systems. J Immunol Methods 1998; 216: 165-181.
29. Ridder R, Schmitz R, Legay F, Gram H. Generation of rabbit monoclonal antibody fragments from a combinatorial phage display library and their production in the yeast Pichia pastoris. Nat Biotechnol 1995; 13: 255-260.